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Background: The equine influenza (EI) is an infectious and contagious disease of the upper respiratory tract of horses.
Two outbreaks were notified in Morocco during 1997 and 2004 respectively in Nador and Essaouira. The aims of the
present study concern the amino acids sequences comparison with reference strain A/equine/Miami/1963(H3N8) of
the HA2 subunit including the cleavage site of three equine influenza viruses (H3N8) isolated in Morocco: A/equine/
Nador/1/1997(H3N8), A/equine/Essaouira/2/2004 (H3N8) and A/equine/Essaouira/3/2004 (H3N8).
Results: The obtained results demonstrated that the substitutions were located at Ectodomain (ED) and transmembrane
domain (TD), and they have only one arginine in cleavage site (HA1-PEKQI-R329-GI-HA2). In the Ectodomain, the
mutation N/1542/T deleted the NGT glycosylation site at position 154 for both strains A/equine/Essaouira/2/2004
(H3N8) and A/equine/Essaouira/3/2004(H3N8). Except for mutation D/1602/Y of the A/equine/Nador/1/1997(H3N8)
strain, the other mutations were involved in non conserved sites. While the transmembrane domain (TM) of the strain
A/equine/Essaouira/3/2004(H3N8) exhibits a substitution at residue C/1992/F. For the A/equine/Nador/1/1997(H3N8)
strain the HA2 shows a mutation at residue M/2072/L. Three Moroccan strains reveals a common substitution at the
residue E/2112/Q located between transmembrane domain TM and the cytoplasmic domain (CD).
Conclusion: The given nature virulence of three Moroccan strains, the identified and reported mutations certainly
played a permissive role of infection viral process.
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In Morocco horses play a significant socio-economic role,
but their health status is threatened by the occurrence of
many infectious and contagious diseases such as equine
influenza (EI), equine viral arteritis, rhino-pneumonia and
West Nile disease. However, EI remains the most alarming
disease that causes significant economic losses, often due
to the unavailability of sportive horses and the decline of
their performance during pulmonary sequels [1-3].
Equine influenza virus is a species-type A influenza virus
from the orthomyxovirus family [4]. Two subtypes of
equine influenza virus H7N7 and H3N8, were identified:
(prototypes A/equine/Prague/1/56(H7N7) and A/equine/* Correspondence: m.ennaji@yahoo.fr
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reproduction in any medium, provided the orMiami/1/63(H3N8) [5,6]. The first subtype (H7N7) is
antigenically stable. Since 1979, no outbreaks have been
reported [7,8]. While, the second subtype (H3N8) con-
tinues to circulate worldwide, and was responsible of all
recent reported outbreaks [9,10]. Since 1989, this virus
has diverged into two antigenically distinct lineages:
Eurasian and American lineages. The last lineage subse-
quently diverged into three sublineages: south America,
Florida (Clades 1 and 2) and Kentucky [4].
The genome of equine influenza virus (EIV) consists in
of eight RNA segments encoding 11 proteins: polymerase
polypeptides: PB1, PA, PB2, surface glycoproteins hemag-
glutinin (HA) and neuraminidase (NA), major nucleocapsid
protein (NP), matrix protein (M1), ionic channel protein
(M2), nonstructural anti-interferon protein (NS1), nuclear
export protein (NEP), and some strains of EIV also express
a recently discovered PB1-F2 mitochondrial proteinral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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a predominantly mitochondrial localization.
The hemagglutinin is a glycoprotein encoded by segment
4 of the viral genome and synthesized as a precursor
form (HA0) (75 kDa) of 550 amino acids by the ribosomes
associated with endoplasmic reticulum [14].
The association of three monomers (HA0) forms a
homo-trimer projected form spicules on the surface of
the viral particle of 135 A [15]. It consists in two poly-
peptides, HA1 of 328 amino acids (50 kDa) and HA2
of 221 amino acids (25KDa), linked to each other by a
disulfide bond between residues 14 of the HA1 and
137 of the HA2 [16,17]. The cleavage of HA0 occurs
at arginine conserved residue 329 of the cleavage site,
which includes 19 residues (323–328 of HA1, 329 and
1–12 of HA2 [18].
In the low virulent strains limited to the respiratory
tract, this site is usually a unique arginine (eg: HA1-
PEKQI-R329-GI-HA2 of the strain A/equine/Miami/1963
(H3N8)/AAA43164). In contrast with the highly patho-
genic avian strains, this cleavage site consists in several
basic residues, forming a consensus sequence type R-X-
K/R-R. (eg: HA1-PQRERRRKKR329-GL-HA2 of the strain
A/Chicken/Hong Kong/258/97(H5N1)/AAC14418). In
the cleavage site of highly pathogenic avian influenza
viruses (HPAIV), the “RRRKKR” sequence represents the
pathogenic cleavage site motif [19].
Habitually, different proteases recognize monobasic
sequences and cleave HA0 into HA1 and HA2 [20]. One
of them is the tryptase Clara (extracellular protease).
Though the HAs in the multibasic site would be cleaved
by ubiquitous proteases such as furin (intracellular prote-
ase present in the Golgi apparatus), which leads to a much
broader tropism of the virus leading to severe systemic
infection [21-24].
The HA2 exhibits a relatively high degree of conservation
[25,26] and forms the basis of the structural-functional
fusogenic activity, which is often considered as one of
the essential biological properties of viral infection [27].
Residues 1–185 are the ectodomain (ED) within the N-
terminal extremity of 22 amino acid representing the
“fusion peptide (PF)”[28], the residues 185–211 are the
transmembrane domain (TM) and finally residues 211–221
form the cytoplasmic domain (CD) embedded within the
viral particle [17,29].
Through this paper, we will develop the study of the
amino acid sequences of the HA2 sub-unit and cleavage
site of three strains isolated in Morocco: A/equine/
Nador/1/1997(H3N8), A/equine/Essaouira/2/2004(H3N8),
A/equine/Essaouira/3/2004(H3N8) [30] and their compari-
son with those of the equine influenza strains available
in the Genbank database, including strains recently iso-
lated in Algeria by Laabassi et al., [31]. Results released
concerning the equine influenza strains isolated in theArabian Maghreb are likely on the HA1 subunit and more
particularly on the antigenic sites [30,31].
Methods
Viruses
A/equine/Nador/1/97(H3N8) was isolated in Nador from
a mule using 11-day-old specific-pathogen-free chicken
eggs as described by Kissi [32]. A/equine/Essaouira/2/
2004(H3N8) and A/equine/Essaouira/3/2004(H3N8) were
isolated from diseased donkey and a horse, respectively,
during 2004 outbreaks in Essaouira. Comparing to the
epizootic of 1997, the epizootic of 2004 was notified by
the international organization of epizootics [33].
The isolates from Essaouira outbreaks were passaged
on Madin-Darby canine kidney (MDCK) cells at 34°C in
an atmosphere of 5% CO2 in Eagle’s minimum essential
medium supplemented with 5% FCS [34].
Viral RNA extraction and amplification
Viral RNA was directly extracted from isolates using a
Purlink viral RNA/DNA-Minikit (Invitrogen, UK) follow-
ing the manufacturer’s recommended protocol. PCR was
performed by Platinum® PCR SuperMix High Fidelity kit
(Invitrogen, UK) on cDNA obtained using primers specific
for HA1F (CAGGGGATATTTCTGTCAATCATG) HA1R
(GCTGCTTGAGTGCTCTTTAGATC), HA2F (ATTA
CACCAAATGGAAGCATC) and HA2R (AGTAGAAA
CAAGGGTGTTTTTAAC) at a final concentration of
0.5 μM for primers. Primer design is detailed by Tissier
et al. [35]. The thermal cycle was programmed as
followed: an incubation at 95°C for 2 min, and then
35 cycles of denaturation at 95°C for 30s, 52°C for
1 min for hybridization of HA1 and 48°C for 1 min for
HA2 primer hybridization, 72°C for 30s.
Sequencing HA genes
The amplified HA (HA1 and HA2) products were se-
quenced. Briefly, the PCR products were purified using
EXOSAP-IT (USB) and bidirectionally sequenced by using
ABI BigDye1 Terminator v3.1 (Applied Biosystems) on an
ABI 3130xl sequencer (Applied Biosystems). Analysis of
the produced electrophoregramm was carried out with
the sequencing Analysis Software version 5.3.1 (Applied
Biosystems). The HA gene in its entirety was sequenced,
HA1 and HA2 two polypeptides, which are representing
the two subunits of the protein. Subsequently, these
sequences were assembled to reconstruct the entire
HA; for this purpose, the primers were selected and the
two segments overlapped [35].
Phylogenetic analysis and sequences alignment
We performed phylogenetic analysis of 39 equine influenza
strains (including Moroccan and Algerian isolates) pub-
lished in GenBank database, selected using the neighbor-
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HA sequence was the root. The tree was visualized using
MEGA5.1 software (http://megasoftware.net/) [37].
Multiple alignments of the amino acid sequence of HA2
of Moroccan strains were used by Basic Local Alignment
Search Tool (BLAST) and MEGA5.1 software.
Results and discussion
The nucleotide sequences of hemagglutinin of the three
Moroccan isolates: A/equine/Nador/1/1997(H3N8), A/
equine/Essaouira/2/2004(H3N8) and A/equine/Essaouira/
3/2004(H3N8) are recorded in “GenBank” database under
the following accession numbers: JQ955607, JQ955609
and JQ955612.
Between 1972 and 2011, fourteen equine influenza
strains have been isolated in the Maghrebian Arab region.
Their phylogenetic analyses showed their relationships in
the various stages of antigenic evolution (Predivergence,
European and American lineages) [30,31].
The strains A/equine/Essaouira/2/2004, A/equine/Essa-
ouira/3/2004 and A/equine/Algiers/1972 show a high
homology with reference strain (A/equine/Miami/63)
belonging therefore to the predivergence phase (Figure 1).
While A/equine/Nador/1/1997 strain was clustered with
the Eurasian lineage viruses, exhibiting the highest hom-
ology to the influenza viruses in equine infected in Italy in
the early nineties (i.e. A/equine/Italy/1199/1992) [30].
In 2011, ten strains of equine influenza (A/equine/
Tiaret/1/ 2011 to A/equine/Tiaret/10/2011) were isolated
by Laabassi and colleagues in Tiaret (the west of Algeria).
These strains belong to the American lineage and Florida
sublignage (clade 2) [31] (Figure 1).
The comparison of the amino acid sequences of the HA2
of three strains isolated in Morocco and the reference
strain A/equine/Miami/1963(H3N8) shows that the strain
A/equine/Nador/1/1997(H3N8) present ten substitutions
at the residues respectively: F/562/I, K/582/R, E/852/D,
N/1352/G, E/1502/G, D/1602/Y, R/1742/K, G/1752/S, M/
2072/L and E/2112/Q. In both strains A/equine/Essaouira/
2/2004(H3N8) and A/equine/Essaouira/3/2004(H3N8),
the HA2 represents four common mutations at the
residues: F/562/I, N/1542/T, D/1582/N and E/2112/Q
and an additional substitution at residue C/1992/F for
the strain A/equine/Essaouira/3/2004(H3N8) (Table 1).
The strain A/equine/Algiers/1972 has eight substitutions
at the residues: Q/3271/R, I/3281/L, Y/262/H, F/562/I,
A/1012/T, K/1212/R, G/1752/S and E/2112/Q.
Ten Algerian strains (A/equine/Tiaret/1/2011 to A/
equine/Tiaret/10/2011) presented nine common muta-
tions at residus: A/432/T, G/502/E, F/562/I, K/582/R, N/
1352/G, E/1502/G, D/1602/Y, R/1742/K, E/2112/Q. both
strains A/equine/Tiaret/10/2011 and A/equine/Tiaret/
6/2011 show additional mutation respectively at residue
I/3281/V et K/622/C. The impact of adjacent aminoacids of HA cleavage site on virulence was studied by
several authors [38].
The hemagglutinin of the three isolated strains in
Morocco A/equine/Nador/1/1997, A/equine/Essaouira/
2/2004(H3N8) and A/equine/Essaouira/3/2004 (H3N8)
have a single conserved arginine at the residue 329
(R329), while the strain A/equine/Algiers/1972 (H3N8)
shows two arginines at the residues 327 and 329 (Q/
3271/R, R329) (HA1-RXR329-GI-HA2). Mutations leading
to the acquisition of basic amino acids are also observed
for the strains A/equine/Tokyo/2/1971(H3N8) (Q/3271/R,
HA1-RXR329-GI-HA2), A/equine/Uruguay/1/1963(H3N8)
(K/3261/R, HA1-RXXR329-GI-HA2), A/equine/Sao Paulo/
6/1963 (H3N8) (K/3261/R et Q/3271/R, HA1-RRXR329-
GI-HA2 and A/equine/Sachiyama/1/1971 (H3N8) (Q/
3271/R, HA1-RXR329-GI-HA2) (Figure 1).
Interestingly, these mutations do not corroborate the
consensus sequence of the high pathogenic avian virus
H5 and H7 (HA1-RRRKKR329- GL-HA2) [24].
Figure 2 shows a cleavage sites sequences comparison
with the highly pathogenic avian strain A/Chicken/Hong
Kong/258/97 (H5N1)/AAC14418). It’s worth noting that
a pathogenic cleavage site motif “RRRKKR” is absent in
the cleavage site of the equine influenza virus (H3N8).
However, Bogs et al., 2010, reported that the introduction
of such a polybasic motif into the HA cleavage site of a
low-pathogenic H3N8 strain did not lead to transform-
ation into an HPAIV indicating the existence of additional
virulence determinants in the HA and/or the other viral
proteins [39].
Furthermore, the passage of a monobasic cleavage site to
another polybasic represents a potential risk of increased
virulence and spread of influenza infection [19].
The mutations at the cleavage site by basic amino acids
for EIVs are exceptional. The result of the alignment of
132 hemagglutinin sequences (H3) (full length) of EI with
available sequences on the Genbank database was made.
Only nine sequences (ACF22126, AAA43100, ACI25735,
ACD85385, ACD85264, AAA43111, AEM60147, AAA
43114, and ACD85418) have at least two arginines at
the cleavage site. The three types of sequences HA1-
RXR329-GI-HA2, HA1-RXXR329-GI-HA2 and HA1-
RRXR329-GI-HA2 are noticed.
Among 23 amino acids “GIFGAIAGFIENGWEGMV
DGWYG” corresponding to the sequence of the fusion
peptide of the three Moroccan isolated and the used
aligned strains, the four residues 20–23 (GWYG) are
completely conserved which include two hydrophobic
residues of Glycine [23].
Additionally, the result of amino acid alignment shows
no mutation compared to the reference strain A/equine/
Miami/1963. The high conservation of the N-terminal
region of the HA2 sequences, especially for the first 11
amino acids “GIFGAIAGFIE”, with few rare mutations,
Figure 1 Phylogenetic tree obtained by comparing amino acid sequences for 30 strains derived from the hemagglutinin gene HA1
(1–329 aa). Accession numbers: A/equine/Miami/1963, AAA43164; A/equine/Uruguay/1/1963, AAA43114 ; A/equine/Tokyo/1971, AAA43111; A/
equine/Algiers/1972 , ACF22126; A/equine/Fontainbleu/1/1979, ACD85396; A/equine/Romania/1/1980, ACD85374; A/equine/Kentucky/1/1987,
ACA24568;A/equine/Suffolk/89, CAA48482; A/equine/Yvelines/2136/89 ,BAA33940 ; A/equine/Ibadan/6/91, CAA64893; A/equine/Rome/5/1991,
ACD85341; A/equine/Italy/1199/1992 ,ACD85308; A/equine/Florida/1/93, AAB36978; A/equine/LaPlata/1/93,BAA33947; A/equi 2/Avesta/93, CAA74385 ;
A/eq/Newmarket/2/93, CAA59416; A/equine/Dubai/48/1995, AEI26218; A/equine/Nador/1/1997, AFJ69903; A/equine/Grobois/1/1998, ACH95594; A/
equine/Ohio/1/2003, ABA39846 ; A/equine/Essaouira/3/2004, AFJ69909; A/equine/Spain/1/2007, ADO78886; A/equine/Egypt/6066NAMRU3-VSVRI/2008
(A/equine/Egypt/2008), ACH95682; A/equine/Essaouira/2/2004 ,AFJ69905; A/equine/Athens/04/2007, ADF55752; A/equine/Berlin/13/02, ABP35588 ;
equine/Brescia/1999 ,ABU46321 ; A/equine/Brno/1/1997 , AEI26221; A/equine/South Africa/4/2003, ADB45165; A/equine/Richmond/1/2007, ACH95569;
A/equine/Tiaret/1/2011, AGR54591; A/equine/Tiaret/2/2011, AGR54592; A/equine/Tiaret/3/2011, AGR54593; A/equine/Tiaret/4/2011, AGR54594;
A/equine/Tiaret/5/2011, AGR54595; A/equine/Tiaret/6/2011, AGR54596 ;A/equine/Tiaret/7/2011, AGR54597 ; A/equine/Tiaret/8/2011 ,AGR54598;
A/equine/Tiaret/9/2011, AGR54599; A/equine/Tiaret/10/2011, AGR54600.
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A. Currently, this conserved region of HA2 and of the
M2e (ectodomain M2 ion-channel protein) form the
basis of the research for the development of a universal
vaccine [40,41].The three segments (residues 34–37) of the homo-
trimer comb the cap of the N-terminal triple-stranded
coiled coil forming a small ring. Even more, the annular
space formed is stabilized by the triple contact between
the methyl groups of Ala-35 and Ala-36, which are
Table 1 Mutations comparison of 21 protein sequences of the Hemagglutinin subunit HA2
Cleavage site
Ectodomain
FP Shortβ sheet Helix A Helix B Helix c Coiled coil
HA residual 323 325 326 327 328 347 355 369 372 379 385 386 387 391 414 430 431
HA2 Residual -6 -4 -3 -2 -1 18 26 40 43 50 56 57 58 62 85 101 102
A/equine/Miami/1963 V E K Q I V Y S A G F E K K E A L
A/equine/Nador/1/1997 . . . . . . . . . . I . R . D . .
A/equine/Essaouira/2/2004 . . . . . . . . . . I . . . . . .
A/equine/Essaouira/3/2004 . . . . . . . . . . I . . . . . .
A/equine/Algiers/1/1972 . . . R L . H . . . I . . . . T .
A/equine/Tokyo/2/1971 I G . R L I H . . . I . . . . T .
A/equine/Uruguay/1/1963 . . R . . I . . . . I G . . . . .
A/equine/Sao Paulo/6/1963 . . R R L I . . . . I G . . . . I
A/equine/Sachiyama/1/1971 I . . R L I H . . . I . . . . T .
A/equine/Italy/1199/1992 . . . . . . . . . . I . R . . . .
A/equine/Egypt/2008 . . . . . . . . . . I . R . . . .
A/equine/Tiaret/1/2011 . . . . . . . . T E I . R . . . .
A/equine/Tiaret/2/2011 . . . . . . . . T E I . R . . . .
A/equine/Tiaret/3/2011 . . . . . . . . T E I . R . . . .
A/equine/Tiaret/4/2011 . . . . . . . . T E I . R . . . .
A/equine/Tiaret/5/2011 . . . . . . . . T E I . R . . . .
A/equine/Tiaret/6/2011 . . . . . . . . T E I . R . . . .
A/equine/Tiaret/7/2011 . . . . . . . . T E I . R . . . .
A/equine/Tiaret/8/2011 . . . . . . . . T E I . R . . . .
A/equine/Tiaret/9/2011 . . . . . . . . T E I . R . . . .




















Helix D Helix E-H
HA residual 450 462 464 465 476 479 483 486 487 489 492 496 503 504 527 528 536 540
HA2 Residual 121 133 135 136 147 150 154 157 158 160 163 167 174 175 198 199 207 211
A/equine/Miami/1963 K M N G A E N Y D D R L R G I C M E
A/equine/Nador/1/1997 . . G . . G . . . Y . . K S . . L Q
A/equine/Essaouira/2/2004 . . . . . . T . N . . . . . . . . Q
A/equine/Essaouira/3/2004 . . . . . . T . N . . . . . . F . Q
A/equine/Algiers/1/1972 R . . . . . . . . . . . . S . . . Q
A/equine/Tokyo/2/1971 R I . . . . . . . . . . . . . . . Q
A/equine/Uruguay/1/1963 . . . . . . . . . . K . . . . . . Q
A/equine/Sao Paulo/6/1963 . . . R T . . . N . . V K . . . . Q
A/equine/Sachiyama/1/1971 R I . . . . . . . . . . . . . . . Q
A/equine/Italy/1199/1992 . . G . . G . . . Y . . K S . . . Q
A/equine/Egypt/2008 . . G . . G . . . Y . . K . V . . Q
A/equine/Tiaret/1/2011 . . G . . G . . . Y . . K . . . . Q
A/equine/Tiaret/2/2011 . . G . . G . . . Y . . K . . . . Q
A/equine/Tiaret/3/2011 . . G . . G . . . Y . . K . . . . Q
A/equine/Tiaret/4/2011 . . G . . G . . . Y . . K . . . . Q
A/equine/Tiaret/5/2011 . . G . . G . . . Y . . K . . . . Q
A/equine/Tiaret/6/2011 . . G . . G . C . Y . . K . . . . Q
A/equine/Tiaret/7/2011 . . G . . G . . . Y . . K . . . . Q
A/equine/Tiaret/8/2011 . . G . . G . . . Y . . K . . . . Q
A/equine/Tiaret/9/2011 . . G . . G . . . Y . . K . . . . Q
A/equine/Tiaret/10/2011 . . G . . G . . . Y . . K . . . . Q
Accession numbers: A/equine/Miami/1963, AAA43164; A/equine/Nador/1/1997, AFJ69903; A/equine/Essaouira/2/2004, AFJ69905; A/equine/Essaouira/3/2004, AFJ69909; A/equine/Algiers/1/1972, ACF22126; A/equine/
Italy/1199/1992, ACD85308; A/equine/Sachiyama/1/1971, ACI25735; A/equine/Sao Paulo/6/1963, ACD85264; A/equine/Egypt/6066NAMRU3-VSVRI/2008 (A/equine/Egypt/2008), ACH95682; A/equine/Uruguay/1/1963,
ACD85418; A/equine/Tokyo/2/1971, AEM60147; A/equine/Tiaret/1/2011, AGR54591; A/equine/Tiaret/2/2011, AGR54592; A/equine/Tiaret/3/2011, AGR54593; A/equine/Tiaret/4/2011, AGR54594; A/equine/Tiaret/5/2011,



















Figure 2 Multiple alignment of 24 sequences of cleavage site (Hemagglutinin HA2). (Red line: sequence forming pathogenic cleavage site
motif). Accession numbers: A/Chicken/Hong Kong/258/97(H5N1), AAC14418; A/equine/Miami/1963, AAA43164; A/equine/Nador/1/1997, AFJ69903; A/
equine/Essaouira/2/2004, AFJ69905; A/equine/Essaouira/3/2004, AFJ69909; A/equine/Algiers/1/1972, ACF22126; A/equine/Italy/1199/1992 , ACD85308; A/
equine/Otar/764/2007, ADZ55424; A/equine/Sachiyama/1/1971, ACI25735; A/equine/Sao Paulo/6/1963, ACD85264; A/equine/Egypt/6066NAMRU3-VSVRI/
2008 (A/equine/Egypt/2008), ACH95682; A/equine/Uruguay/1/1963, ACD85418; A/equine/Tokyo/2/1971, AEM60147; A/equine/Sussex/1/1989, ACD97425;
A/equine/Tiaret/1/2011, AGR54591; A/equine/Tiaret/2/2011, AGR54592; A/equine/Tiaret/3/2011, AGR54593; A/equine/Tiaret/4/2011, AGR54594; A/equine/
Tiaret/5/2011, AGR54595; A/equine/Tiaret/6/2011, AGR54596 ;A/equine/Tiaret/7/2011, AGR54597 ; A/equine/Tiaret/8/2011 ,AGR54598; A/equine/Tiaret/9/
2011, AGR54599; A/equine/Tiaret/10/2011, AGR54600.
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the long alpha helix composed of 68 residues (38–105),
which consists of three helices A (residues 38–55), B
(residues 56–75) and C (76–105) [15], the strains A/
equine/Algiers/1972(H3N8) A/equine/Essaouira/2/2004
(H3N8) and A/equine/Essaouira/3/2004(H3N8) have a
common single substitution at residue F/562/I.
Moreover, the strain A/equine/Algiers/1972(H3N8) has
a second mutation at residue A/1012/T. For the strain
A/equine/Nador/1/1997(H3N8), the HA2 has three
mutations at the residues F/562/I, K/582/R, E/852/D. At
the helix D (106–129), the strain A/equine/Algiers/1972
(H3N8) has a single substitution at residue K/1212/R. At
the helix formed E-H residues (130–175), the strain A/
equine/Nador/1/1997(H3N8) presents four mutations at
the residues E/1502/G, D/1602/Y, R/1742/K and G/1752/S.
Considerably, the mutation D/1602/Y of the strain A/
equine/Nador/1/1997(H3N8) localized on a conserved
site, which characterizes the viruses of subtype (H3)
[22]. The A/equine/Algiers/1972(H3N8) strain exhibits a
substitution at residue G/1752/S. Regarding the A/equine/
Essaouira/2/2004(H3N8) strain and A/equine/Essaouira/
3/2004(H3N8) strain, the HA2 presents two common
mutations at the residues N/1542/T et D/1582/N. The first
mutation (N/1542/T) affects a glycosylation site (Figure 1).
This mutation removed the NGT glycosylation site at
position 154, which, could affect the structure, flexibility,
and solvent exposure of this region. However, the recentadaptation of equine H3N8 virus to dogs is associated
with five HA mutations, which include the N1542T [42].
At the transmembrane domain TM of the strain A/
equine/Essaouira/3/2004(H3N8) exhibits a substitution at
residue C/1992/F. For the A/equine/Nador/1/1997(H3N8)
strain the HA2 shows a mutation at residue M/2072/L.
The four Maghreb strains reveals a common substitution
at the residue E/2112/Q situated between transmembrane
domain TM and the cytoplasmic domain (CD).
Indeed, the occurrence of severe respiratory signs in
the infected horses, obviously confirm that the enrolled
four strains in this study are virulent in nature.Conclusion
Although the amino acid sequences of the HA2 subunit
are relatively stable, several mutations compared to the
reference strain A/equine/Miami/1963 were found for
the four strains of the Arabic Maghreb. Apart from the
mutation D/1602/Y of the strain A/equine/Nador/1/1997
(H3N8), Q/3271/R of the strain A/equine/Algiers/1972
(H3N8) and N/1542/T of both strains A/equine/Essaouira/
2/2004 (H3N8)and A/equine/Essaouira/3/2004(H3N8), the
other mutations were involved at not conserved sites at
helices B, C, D, E-H and TM.Competing interests
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